The Pharma Legal Handbook: Peru

Peru is one of the Andean region's most important pharmaceutical markets, with a regulatory framework administered by the Directorate General of Medicines, Supplies and Drugs (DIGEMID). Peru's market has grown substantially in recent years, driven by economic growth, expanding health insurance coverage under SIS, and a growing private healthcare sector.

Peru operates a price control system for essential medicines and a monitored price regime for other products, with DIGEMID managing maximum price notifications. The public procurement market, managed through CENARES and the regional health authorities, represents a significant commercial channel for companies with products on the national essential medicines list.

The Pharma Legal Handbook: Peru provides comprehensive guidance on pharmaceutical regulation in Peru, covering DIGEMID product registration, pricing frameworks, public procurement rules, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, and intellectual property protection.